You are here
In global race for cancer therapy, a Chinese biotech firm surges
IN THE global race to use human immune cells to fight cancers, a little-known Chinese firm called GenScript Biotech Corp is emerging as one of the biggest stock gainers.
Among the first Chinese developers of so-called CAR-T cancer therapies, GenScript's shares have risen
- CALL +65 6388 3838
- EMAIL email@example.com